Oramed Pharmaceuticals Inc

ORMPNASDAQ · USD
4.79USD+0.07 (+1.49%)
8110

Oramed Pharmaceuticals Inc (ORMP) Unusual Options Activity Today

ORMP options volume power reached 0.33x on the previous trading day. The highest reading was on the $5 CALL expiring 2026-10-16.

Read more

Checking ORMP unusual options activity helps you spot when traders are making outsized bets on Oramed Pharmaceuticals Inc before the broader market catches on. Oramed Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ORMP unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ORMP unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ORMP unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ORMP unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule.

The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Catalysts rarely arrive without a footprint, and ORMP unusual options activity is often where that footprint shows up first. Our scanner tracks Oramed Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ORMP unusual options volume on the call side or chasing put sweeps, Oramed Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
2.500.204.402.30196%00—
5.000.050.200.1349%040.00%
7.50—0.100.10144%00—
Puts
2.50—2.152.151,000%010.00%
5.000.052.551.30244%00—
7.500.704.902.80115%00—

As of September 23, 2026

Spot unusual options activity before it moves

Track ORMP options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial